Kazumi Shiosaki

Kazumi Shiosaki is the Managing Director at MPM Capital in Boston, Massachusetts, with a background that includes serving as CEO of Epizyme and Primera, as well as holding a senior leadership position at Millennium Pharmaceuticals. Notable career highlights include leading investments in companies like Twentyeight-Seven Therapeutics during their Series A funding round and playing a pivotal role in the Series B funding of Epizyme.